Xiaoxian Li

Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling

Stephen T. C. Wong, Mauro Ferrari, Stephen T C Wong, 2014, Proceedings of the National Academy of Sciences.

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

Susan G Hilsenbeck, Jeffrey Rosen, Jian Huang, 2008, Journal of the National Cancer Institute.

Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma

Jing Zhao, Anil V. Parwani, A. Parwani, 2020, Breast Cancer Research and Treatment.

Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer

Limin Peng, Kevin C Ward, A. Sahin, 2016, Breast Cancer Research and Treatment.

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Jeffrey M. Rosen, Charles M. Perou, Susan G. Hilsenbeck, 2009, Proceedings of the National Academy of Sciences.